Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modification of Intestinal Microbiome in Patients With Primary IgA Nephropathy

NCT07750249 is registered in ClinicalTrials.gov with University Hospital, Martin as lead sponsor.

NCT NCT07750249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07750249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modification of Intestinal Microbiome in Patients With Primary IgA Nephropathy
Lead sponsor
University Hospital, Martin
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
March 1, 2025
Completion date
December 31, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary iga nephropathy